1. Home
  2. ACHL vs ISPO Comparison

ACHL vs ISPO Comparison

Compare ACHL & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • ISPO
  • Stock Information
  • Founded
  • ACHL 2016
  • ISPO 2010
  • Country
  • ACHL United Kingdom
  • ISPO United States
  • Employees
  • ACHL N/A
  • ISPO N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • ISPO Blank Checks
  • Sector
  • ACHL Health Care
  • ISPO Finance
  • Exchange
  • ACHL Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • ACHL 46.0M
  • ISPO 53.5M
  • IPO Year
  • ACHL 2021
  • ISPO N/A
  • Fundamental
  • Price
  • ACHL $1.38
  • ISPO $4.29
  • Analyst Decision
  • ACHL Buy
  • ISPO Buy
  • Analyst Count
  • ACHL 2
  • ISPO 2
  • Target Price
  • ACHL $4.00
  • ISPO $10.50
  • AVG Volume (30 Days)
  • ACHL 1.9M
  • ISPO 20.0K
  • Earning Date
  • ACHL 04-03-2025
  • ISPO 02-24-2025
  • Dividend Yield
  • ACHL N/A
  • ISPO N/A
  • EPS Growth
  • ACHL N/A
  • ISPO N/A
  • EPS
  • ACHL N/A
  • ISPO N/A
  • Revenue
  • ACHL N/A
  • ISPO $287,451,000.00
  • Revenue This Year
  • ACHL N/A
  • ISPO N/A
  • Revenue Next Year
  • ACHL N/A
  • ISPO N/A
  • P/E Ratio
  • ACHL N/A
  • ISPO N/A
  • Revenue Growth
  • ACHL N/A
  • ISPO N/A
  • 52 Week Low
  • ACHL $0.63
  • ISPO $3.11
  • 52 Week High
  • ACHL $1.76
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 72.41
  • ISPO 41.53
  • Support Level
  • ACHL $1.10
  • ISPO $4.35
  • Resistance Level
  • ACHL $1.41
  • ISPO $4.64
  • Average True Range (ATR)
  • ACHL 0.02
  • ISPO 0.36
  • MACD
  • ACHL 0.00
  • ISPO -0.09
  • Stochastic Oscillator
  • ACHL 90.48
  • ISPO 22.06

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About ISPO Inspirato Incorporated

Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.

Share on Social Networks: